Background: Despite advancements in vaccination, early treatments, and understanding of
SARS-CoV-2, its impact remains significant worldwide. Many patients require intensive care …

Abstract Purpose: Coronavirus disease–2019 (COVID-19) continues to be a global threat
and remains a significant cause of hospitalizations. Recent clinical guidelines have …

We aimed to create the prediction model of in‐hospital mortality using machine learning
methods for patients with coronavirus disease 2019 (COVID‐19) treated with steroid and …

Introduction The impact of remdesivir on mortality in patients with COVID-19 is still
controversial. We aimed to identify clinical phenotype clusters of COVID-19 hospitalized …

AIMS OF THE STUDY Remdesivir has shown benefits against COVID-19. However, it
remains unclear whether, to what extent, and among whom remdesivir can reduce COVID …

Importance SARS-CoV-2, which causes COVID-19, poses considerable morbidity and
mortality risks. Studies using data collected during routine clinical practice can supplement …

Background The World Health Organization guidelines did not make a recommendation on
use of remdesivir based on disease severity. Little is known regarding effectiveness of …

Remdesivir is the first drug approved for treatment of COVID-19 but current evidence for
recommending its use for the treatment of moderate-to-severe disease is still controversial …

Background Remdesivir was the first antiviral to show clinical benefit in patients with
moderate-to-severe COVID-19. Previous trials demonstrated a faster time to recovery in …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of SARS-CoV-2. Methods This was a retrospective comparative …